Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (275)
|
Core Tip (296)
|
Full Article (HTML) (1299)
|
Full Article (PDF)-378K (91)
|
Full Article with Cover (PDF)-633K (52)
|
Full Article (XML)-71K (50)
|
Audio-3309K (12)
|
Peer-Review Report-245K (41)
|
Answering Reviewers-157K (41)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2531)
|
Similar Articles (141)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches

World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (309)
|
Core Tip (306)
|
Full Article (HTML) (3834)
|
Figures (1-1) (251)
|
Tables (1-3) (241)
|
Full Article (PDF)-4025K (266)
|
Full Article with Cover (PDF)-4275K (72)
|
Full Article (XML)-507K (47)
|
Audio-1047K (23)
|
Peer-Review Report-271K (38)
|
Answering Reviewers-120K (47)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6178)
|
Similar Articles (333)
|
Timeline of Article Publication (11)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (267)
|
Core Tip (301)
|
Full Article (HTML) (1454)
|
Figures (1-1) (232)
|
Full Article (PDF)-1122K (98)
|
Full Article with Cover (PDF)-1376K (69)
|
Full Article (XML)-113K (43)
|
Audio-412K (13)
|
Peer-Review Report-223K (45)
|
Answering Reviewers-109K (37)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3395)
|
Similar Articles (1761)
|
Timeline of Article Publication (7)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (276)
|
Core Tip (303)
|
Full Article (HTML) (1271)
|
Figures (1-1) (225)
|
Tables (1-6) (216)
|
Full Article (PDF)-876K (66)
|
Full Article with Cover (PDF)-1130K (37)
|
Full Article (XML)-191K (43)
|
Audio-454K (18)
|
Peer-Review Report-229K (36)
|
Answering Reviewers-124K (30)
|
Supplementary Material-657K (40)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (3367)
|
Similar Articles (34)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms

World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (294)
|
Core Tip (301)
|
Full Article (HTML) (1195)
|
Figures (1-4) (232)
|
Tables (1-3) (245)
|
Full Article (PDF)-8140K (94)
|
Full Article with Cover (PDF)-8392K (55)
|
Full Article (XML)-121K (37)
|
Audio-885K (24)
|
Peer-Review Report-197K (48)
|
Answering Reviewers-155K (42)
|
Supplementary Material-123K (36)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3667)
|
Similar Articles (17)
|
Timeline of Article Publication (7)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (279)
|
Core Tip (299)
|
Full Article (HTML) (1110)
|
Figures (1-2) (268)
|
Tables (1-3) (241)
|
Full Article (PDF)-3168K (87)
|
Full Article with Cover (PDF)-3422K (53)
|
Full Article (XML)-97K (50)
|
Audio-586K (16)
|
Peer-Review Report-221K (54)
|
Answering Reviewers-311K (46)
|
Supplementary Material-128K (46)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (3485)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA

World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (261)
|
Core Tip (277)
|
Full Article (HTML) (944)
|
Figures (1-6) (232)
|
Full Article (PDF)-10367K (76)
|
Full Article with Cover (PDF)-10622K (77)
|
Full Article (XML)-108K (43)
|
Audio-200K (10)
|
Peer-Review Report-203K (46)
|
Answering Reviewers-316K (77)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2362)
|
Similar Articles (1183)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway

World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (248)
|
Core Tip (254)
|
Full Article (HTML) (1149)
|
Figures (1-8) (253)
|
Full Article (PDF)-42475K (97)
|
Full Article with Cover (PDF)-42729K (58)
|
Full Article (XML)-113K (38)
|
Audio-352K (12)
|
Peer-Review Report-309K (34)
|
Answering Reviewers-116K (36)
|
Supplementary Material-190K (35)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2620)
|
Similar Articles (139)
|
Timeline of Article Publication (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (243)
|
Core Tip (271)
|
Full Article (HTML) (1110)
|
Figures (1-6) (235)
|
Tables (1-1) (217)
|
Full Article (PDF)-10815K (82)
|
Full Article with Cover (PDF)-11065K (60)
|
Full Article (XML)-143K (45)
|
Audio-400K (12)
|
Peer-Review Report-253K (42)
|
Answering Reviewers-98K (41)
|
Supplementary Material-270K (49)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3379)
|
Similar Articles (18)
|
Timeline of Article Publication (2)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells

World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (260)
|
Core Tip (288)
|
Full Article (HTML) (1072)
|
Figures (1-7) (237)
|
Full Article (PDF)-9623K (84)
|
Full Article with Cover (PDF)-9876K (52)
|
Full Article (XML)-121K (35)
|
Audio-824K (13)
|
Peer-Review Report-275K (35)
|
Answering Reviewers-363K (38)
|
Supplementary Material-48K (35)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2657)
|
Similar Articles (1743)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?

World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (279)
|
Core Tip (297)
|
Full Article (HTML) (642)
|
Figures (1-1) (237)
|
Tables (1-2) (237)
|
Full Article (PDF)-471K (53)
|
Full Article with Cover (PDF)-728K (35)
|
Full Article (XML)-61K (40)
|
Audio-512K (16)
|
Peer-Review Report-257K (32)
|
Answering Reviewers-156K (38)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2170)
|
Similar Articles (24)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (276)
|
Core Tip (302)
|
Full Article (HTML) (921)
|
Tables (1-1) (264)
|
Full Article (PDF)-370K (70)
|
Full Article with Cover (PDF)-625K (45)
|
Full Article (XML)-56K (41)
|
Audio-2970K (12)
|
Peer-Review Report-217K (37)
|
Answering Reviewers-149K (35)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2307)
|
Similar Articles (162)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (284)
|
Core Tip (286)
|
Full Article (HTML) (2371)
|
Figures (1-1) (244)
|
Full Article (PDF)-1500K (103)
|
Full Article with Cover (PDF)-1754K (57)
|
Full Article (XML)-97K (42)
|
Audio-476K (17)
|
Peer-Review Report-468K (36)
|
Answering Reviewers-1818K (47)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3859)
|
Similar Articles (239)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed

World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (272)
|
Core Tip (293)
|
Full Article (HTML) (873)
|
Figures (1-1) (225)
|
Tables (1-1) (232)
|
Full Article (PDF)-578K (65)
|
Full Article with Cover (PDF)-834K (95)
|
Full Article (XML)-91K (27)
|
Audio-833K (12)
|
Peer-Review Report-243K (27)
|
Answering Reviewers-100K (26)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2460)
|
Similar Articles (1743)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (270)
|
Core Tip (300)
|
Full Article (HTML) (2025)
|
Full Article (PDF)-406K (146)
|
Full Article with Cover (PDF)-661K (108)
|
Full Article (XML)-95K (44)
|
Audio-989K (14)
|
Peer-Review Report-215K (32)
|
Answering Reviewers-118K (46)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3345)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy

World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (256)
|
Core Tip (262)
|
Full Article (HTML) (730)
|
Tables (1-1) (231)
|
Full Article (PDF)-366K (62)
|
Full Article with Cover (PDF)-621K (87)
|
Full Article (XML)-45K (41)
|
Audio-1658K (16)
|
Peer-Review Report-175K (27)
|
Answering Reviewers-38K (37)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2148)
|
Similar Articles (1794)
|
Timeline of Article Publication (0)
|
Authors Evaluation (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open